Delta-Sleep-Inducing Peptide: The First Natural Sleep Molecule Discovered | Research

The takeaway

DSIP is a small peptide found naturally in the brain and blood that induces deep sleep across multiple species and also affects neurotransmitters, hormones, circadian rhythms, and drug withdrawal.

9 amino acids
DSIP is a tiny nonapeptide (MW 849) that was one of the first purified natural sleep factors, inducing delta (deep) sleep across multiple mammalian species including humans

What the researchers found

Delta-sleep-inducing peptide (DSIP) is a nonapeptide (nine amino acids, molecular weight 849) that primarily induces delta sleep (deep, slow-wave sleep) in rabbits, rats, mice, and humans, while in cats it more strongly affects REM sleep. The peptide was one of only two purified and characterized sleep-inducing peptides at the time of this review.

DSIP shows a U-shaped dose-response curve — meaning both too little and too much are less effective, with an optimal middle dose. DSIP-like material was found throughout the brain and peripheral organs via immunoassays and was detected in the blood plasma of several mammalian species. Beyond sleep, DSIP affects neurotransmitter levels, circadian rhythms, locomotor activity, hormone levels, psychological performance, and even modifies the effects of neuropharmacological drugs including withdrawal symptoms.

Why it matters

DSIP was among the first peptides identified as a natural sleep factor, supporting the century-old hypothesis that humoral (blood-borne) factors regulate sleep. Its discovery helped establish the concept that the brain uses peptide signaling to control sleep architecture — a field that later expanded dramatically with the discovery of orexin/hypocretin. DSIP's diverse effects beyond sleep (circadian rhythm, drug withdrawal, hormones) also foreshadowed the modern understanding that neuropeptides rarely have just one function.

The numbers in context

9 amino acids · MW 849 · Induces delta (deep) sleep · U-shaped dose-response · Found in brain + peripheral organs + plasma · Effects on sleep, neurotransmitters, circadian rhythm, hormones, drug withdrawal

How the study worked

Comprehensive literature review published in Neuroscience and Biobehavioral Reviews, covering DSIP's discovery, purification, characterization, distribution in the body (via radioimmunoassay and immunohistochemistry), sleep-inducing properties across multiple species, and broader neurological and physiological effects.

Who was studied

Not applicable (review of animal and human studies on DSIP)

What this study cannot tell us

Published in 1984, so reflects early-stage understanding of this peptide. Subsequent research has raised questions about DSIP's specificity as a sleep-inducing agent and whether it functions as a true endogenous sleep factor. The U-shaped dose-response curve makes it difficult to study and interpret. Reproducibility of sleep-inducing effects has been debated in the subsequent literature.

How to read the evidence

This is a comprehensive review from 1984 published in a respected neuroscience journal. It synthesizes the early evidence on DSIP from multiple research groups. However, subsequent research has been mixed on DSIP's specificity and reproducibility as a sleep factor, and the field has evolved substantially since publication.

When this study was published

Published in 1984. This is a historical review representing the early understanding of DSIP. While the basic properties described remain accurate, subsequent decades of research have added complexity and some controversy about DSIP's precise role in sleep regulation.

The bigger picture

DSIP's discovery was a milestone in sleep science and neuropeptide biology. It helped validate the concept that specific peptides regulate sleep states — a paradigm that continues today with orexin/hypocretin research (the loss of which causes narcolepsy). While DSIP itself hasn't become a clinical treatment, it pioneered the idea that peptide-based sleep therapeutics are possible and contributed to our understanding of how the brain's peptide systems control consciousness and rest.

Questions still open

Could DSIP or synthetic analogs be developed as sleep aids that specifically promote deep sleep without the side effects of current sleep medications?
How does DSIP interact with the orexin/hypocretin system that was discovered later?
What explains the U-shaped dose-response curve, and does this biphasic effect limit DSIP's therapeutic potential?

Common questions

What is DSIP and does it actually make you sleep?

DSIP (delta-sleep-inducing peptide) is a naturally occurring nine-amino-acid peptide found in the brain and blood. It was shown to promote deep, slow-wave sleep (delta sleep) in multiple animal species and in early human studies. However, it has a U-shaped dose-response — too much or too little doesn't work well — which has complicated its development as a therapeutic.

Is DSIP used as a sleep supplement today?

DSIP is not an approved medication and is not available as a standard supplement. While some research peptide vendors sell it, its clinical use has not been validated. The original research was foundational for understanding how peptides regulate sleep, but DSIP itself hasn't become a mainstream treatment.

Read the original research

Delta-sleep-inducing peptide (DSIP): a review.

Neuroscience and biobehavioral reviews, 8(1), 83-93

View on PubMed ↗

Citation

Graf, M V; Kastin, A J. (1984). Delta-sleep-inducing peptide (DSIP): a review.. Neuroscience and biobehavioral reviews, 8(1), 83-93.